MiRTLE Medical develops medical devices and software solutions to enable cardiac monitoring inside an MRI, while expanding clinical and operational procedures to improve patient outcomes. With diagnostic-grade 12-lead ECG monitoring products, MiRTLE provides a comprehensive set of technologies that help cardiologists, electrophysiologists, and radiologists.

MRI-COMPATIBLE DIAGNOSTIC-GRADE

  • 12-lead ECG monitor engineered to be safe while eliminating the MRI's interference
  • Provides vital patient health information throughout the imaging process
  • Enables new research and procedures to be developed that will improve patient outcomes

ENABLING NEW PROCEDURES USING THE MRI FOR PRECISE POSITIONING AND REAL-TIME VISUALIZATION

  • Ablation for arrhythmia
  • Targeted chemotherapy
  • Tumor removal

ENABLING CURRENTLY RESTRICTED PATIENTS TO RECEIVE AN MRI

  • Trauma patients
  • High-risk patients (heart disease, heart failure, high blood pressure, stents, pacemakers)
  • Frightened patients including children

MRI installed base: 50,000 WW (US 40%) growing at 3-5% CAGR

300,000 patients annually are excluded from MRI due to inability to monitor the patient’s health

100,000 ablation procedures annually to treat arrhythmia

Millions of patients could benefit from research underway on MRI-based cancer procedures

© 2016-2017 MiRTLE Medical, LLC | 1600 Osgood Street | Suite 2017 | North Andover, MA  01845 | info@mirtlemed.com | 978.688.8825